tag:blogger.com,1999:blog-9818962.post7239034313481451884..comments2024-03-20T13:10:11.477+05:30Comments on nanopolitan: Novartis judgment: Myth and RealityAbihttp://www.blogger.com/profile/06790560045313883673noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-9818962.post-48476480212496533652013-04-07T15:19:27.169+05:302013-04-07T15:19:27.169+05:30Check Arvind Subramanian's comments
http://www...Check Arvind Subramanian's comments<br />http://www.piie.com/blogs/realtime/?p=3525gaddeswaruphttps://www.blogger.com/profile/16509075029154476375noreply@blogger.comtag:blogger.com,1999:blog-9818962.post-23321267922868834062013-04-06T00:53:39.122+05:302013-04-06T00:53:39.122+05:30Small Corrections: Brook Baker is at Northeastern ...Small Corrections: Brook Baker is at Northeastern University, not at Harvard university.<br /><br />Thanks for posting this: somehow all the people shouting "India is hampering innovation" don't realize that contrary to the spin Novartis PR is trying to put on the event, the Supreme Court did not deny Novartis on the grounds that "your drug is too expensive" or "if we grant you the patent, Indian manufacturers will suffer", but on a technical analysis of the new ground and finding that it was simply not "innovative" enough. Now <i>that</i> must be something pretty damning for a company trying to project it as a champion of innovation and lawful intellectual property rights, shouldn't it?Anonymousnoreply@blogger.com